Search

Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts

Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.

We are committed to exemplary ethical and professional conduct both within the company and from our suppliers.

Data Privacy Notice for Customers, Partners, Visitors, Distributors and interested Persons

Boehringer Ingelheim has actively supported Ukrainian civilians throughout the Russian invasion.

Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term with monetary and in kind donations.

EFPIA Transparency Reports